A Phase II Trial of Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias (GTN)
Latest Information Update: 22 Nov 2022
At a glance
- Drugs Avelumab (Primary)
- Indications Gestational trophoblastic disease; Trophoblastic tumour
- Focus Therapeutic Use
- Acronyms TROPHIMMUN
- 16 Nov 2022 Protocol amended as cohort B was stopped for futility.
- 16 Nov 2022 Results of Cohort B (n=7) assessing the safety and efficacy of Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy published in the Gynecologic Oncology
- 27 Jul 2020 Results of cohort A (n=15) published in the Journal of Clinical Oncology